With the recent launch of the U.S. Food and Drug Administration’s (FDA’s) Rare Disease Endpoint Advancement (RDEA) Pilot Program, the clinical research enterprise gains new support for efforts aimed at efficacy endpoint (or clinical outcome) development and the timely approval of drugs and biological products that...
UW Health is looking for 75 people to test a new Lyme disease vaccine that targets more strains of the tick-borne illness than a little-used shot taken off the market more than 20 years ago....
In recognition of National Hispanic Heritage Month The Association of Clinical Resrarch Professionals (ACRP) reached out to some cultural communications professionals to discuss the importance of clear communications between study teams and participants in clinical trials, no matter what their native languages may be....
The world has changed a lot in the 175 years since the founding of the University of Wisconsin. Some history-changing ideas that continue to reverberate around the globe got their start right here on the University of Wisconsin–Madison campus....
Experts say a wider diverse pool of patients needs to be given a chance to participate in clinical research to get rare disease drugs faster to market....
Enrollment in a Phase 1 trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes of Health’s Clinical Center in Bethesda, Maryland. ...
Cassandra Leopard discusses her career path and current role as Regulatory Supervisor for the UW Clinical Trials Institute (CTI)....
Will the introduction of AI systems improve diagnosis, treatment, and research, bringing better and fairer healthcare to all? Or not?...
Being a clinical trial participant, especially in an interventional trial, is a sacrifice of time and body and represents a true commitment on the part of the patient....
Restrictive eligibility criteria has been a concern for many oncology researchers, who believe these trials should reflect a broader real-world population....
